Literature DB >> 3782864

New perspectives on a subclinical form of visceral leishmaniasis.

R Badaro, T C Jones, E M Carvalho, D Sampaio, S G Reed, A Barral, R Teixeira, W D Johnson.   

Abstract

During an epidemiological study of visceral leishmaniasis in an endemic region of Brazil, new perspectives emerged on a subclinical form of the disease. A group of 86 children with antibody to Leishmania were identified. None of these children had a history of leishmaniasis. The children were segregated into four groups: One group remained asymptomatic (n = 20), whereas another developed classic kala-azar within weeks of the index serology (n = 15). The remaining 51 patients initially had subclinical disease; 13 (25%) of these patients progressed to classic kala-azar (mean, five months). The others (75%) resolved their illness after a prolonged period (mean, 35 months). The initial illness in the subclinical group was characterized by hepatomegaly, frequent splenomegaly, intermittent cough, diarrhea, and low-grade fever. Malaise and poor weight gain were common. Giemsa-stained smears and cultures of bone marrow aspirates were usually negative for Leishmania in the absence of symptoms of classic kala-azar.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3782864     DOI: 10.1093/infdis/154.6.1003

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  93 in total

1.  Enzyme-linked immunosorbent assay for recombinant K39 antigen in diagnosis and prognosis of Indian visceral leishmaniasis.

Authors:  R Kumar; K Pai; K Pathak; S Sundar
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

Review 2.  Clinical and experimental advances in treatment of visceral leishmaniasis.

Authors:  H W Murray
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

3.  Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.

Authors:  P C Melby; J Yang; W Zhao; L E Perez; J Cheng
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  A rare case of Visceral leishmaniasis with multiple relapse and multi-drug unresponsive: successfully treated with combination therapy.

Authors:  Nawin Kumar; Prabhat Kumar Sinha; Krishna Pandey; Neena Verma; Chandra Shekhar Lal; Alok Ranjan; Rakesh Bihari Verma; Pradeep Das
Journal:  Int J Clin Pharm       Date:  2011-07-22

5.  A novel Leishmania infantum recombinant antigen which elicits interleukin 10 production by peripheral blood mononuclear cells of patients with visceral leishmaniasis.

Authors:  I Suffia; B Ferrua; X Stien; B Mograbi; P Marty; D Rousseau; K Fragaki; J Kubar
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

6.  Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral Leishmaniasis.

Authors:  R Badaró; C Nascimento; J S Carvalho; F Badaró; D Russo; J L Ho; S G Reed; W D Johnson; T C Jones
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

7.  Asymptomatic Leishmania infection: a new challenge for Leishmania control.

Authors:  Om Prakash Singh; Epco Hasker; David Sacks; Marleen Boelaert; Shyam Sundar
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

8.  Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI.

Authors:  P Vieira; R de Waal-Malefyt; M N Dang; K E Johnson; R Kastelein; D F Fiorentino; J E deVries; M G Roncarolo; T R Mosmann; K W Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

9.  Infection with Leishmania (Leishmania) infantum of 0 to 18-Month-old children living in a visceral leishmaniasis-endemic area in Brazil.

Authors:  Danielle Borges Maciel; Thaís Almeida M Silva; Luciana Inácia Gomes; Edward de Oliveira; Monique Gomes Salles Tibúrcio; Rafael Faria de Oliveira; Daniel Avelar; José Ronaldo Barbosa; Eliana Furtado; Ana Rabello; Luciana de Almeida Silva
Journal:  Am J Trop Med Hyg       Date:  2014-06-16       Impact factor: 2.345

10.  Detection of Leishmania donovani in peripheral blood of asymptomatic individuals in contact with patients with visceral leishmaniasis.

Authors:  Sultana S Banu; Wieland Meyer; Be-Nazir Ahmed; Rady Kim; Rogan Lee
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-05       Impact factor: 2.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.